Seoul National University Hospital:製薬・医療:M&Aディール及び事業提携情報

◆英語タイトル:Seoul National University Hospital - Pharmaceuticals & Healthcare - Deals and Alliances Profile
◆商品コード:DATA904C11539
◆発行会社(調査会社):GlobalData
◆発行日:2018年11月
◆ページ数:20
◆レポート言語:英語
◆レポート形式:PDF
◆納品方法:Eメール
◆対象地域:韓国
◆産業分野:製薬・医療
◆販売価格オプション(消費税別)
Single User(1名様閲覧用)USD250 ⇒換算¥37,000見積依頼/購入/質問フォーム
Site License(同一事業所内共有可)USD500 ⇒換算¥74,000見積依頼/購入/質問フォーム
Enterprisewide License(複数事業所内共有可)USD750 ⇒換算¥111,000見積依頼/購入/質問フォーム
販売価格オプションの説明はこちらでご利用ガイドはこちらでご確認いただけます。
※お支払金額は「換算金額(日本円)+消費税+配送料(Eメール納品は無料)」です。
※本体価格が¥30,000未満のレポートにつきましては、ハンドリングチャージ¥5,000が別途かかります。
※Eメールによる納品の場合、通常ご注文当日〜2日以内に納品致します。
※レポート納品後、納品日+5日以内に請求書を発行し、お客様宛に郵送しますので、請求書発行日より2ヶ月以内に振込をお願いします。
※為替レートは適宜修正・更新しております。リアルタイム更新ではありません。
※弊社H&Iグローバルリサーチ株式会社はGlobalData社の日本における正規販売代理店です。同社発行の企業調査レポートに関するお問い合わせは弊社までお願い致します。
GlobalData社の概要はこちらでご確認いただけます。



【レポートの概要】

Summary
Seoul National University Hospital (SNUH) is a healthcare service provider. It operates as the representative medical center of Korea. The hospital focuses on raising the standards of nation’s healthcare system, medical education, research and patient care. It offers services such as outpatient, inpatient, medical examination, billing and insurance, issuance service, emergency service and home care services. SNUH through its Department of Education and Research provides educational and training services for professors, specialists, residents, students and staff; and through its SNU Biomedical Research Institute carries out clinical research activities. The hospital’s International Healthcare Center provides medical services for international patients and offers services such as primary medical care, medical examination, follow-up of chronic adult disease, visa medical examination, cancer screening, and aviation medicine consultation services, among others. The hospital operates through its branches including Children’s Hospital, Cancer Hospital, Healthcare System Gangnam Center, Bundang Hospital, and Boramae Hospital. SNUH is headquartered in Seoul, South Korea.

Seoul National University Hospital – Pharmaceuticals & Healthcare – Deals and Alliances Profile provides you comprehensive data and trend analysis of the company’s Mergers and Acquisitions (M&As), partnerships and financings. The report provides detailed information on Mergers and Acquisitions, Equity/Debt Offerings, Private Equity, Venture Financing and Partnership transactions recorded by the company over a five year period. The report offers detailed comparative data on the number of deals and their value categorized into deal types, sub-sector and regions.

GlobalData derived the data presented in this report from proprietary in-house Pharma eTrack deals database, and primary and secondary research.

Scope

- Financial Deals – Analysis of the company’s financial deals including Mergers and Acquisitions, Equity/Debt Offerings, Private Equity, Venture Financing and Partnerships.
- Deals by Year – Chart and table displaying information encompassing the number of deals and value reported by the company by year, for a five year period.
- Deals by Type – Chart and table depicting information including the number of deals and value reported by the company by type such as Mergers and Acquisitions, Equity/Debt Offering etc.
- Deals by Region – Chart and table presenting information on the number of deals and value reported by the company by region, which includes North America, Europe, Asia Pacific, the Middle East and Africa and South and Central America.
- Deals by Sub-sector – Chart and table showing information on the number of deals and value reported by the company, by sub-sector.
- Major Deals – Information on the company’s major financial deals. Each such deal has a brief summary, deal type, deal rationale; and deal financials and target Company’s (major public companies) key financial metrics and ratios.
- Business Description – A brief description of the company’s operations.
- Key Employees – A list of the key executives of the company.
- Important Locations and Subsidiaries – A list and contact details of key centers of operation and subsidiaries of the company.
- Key Competitors – A list of the key competitors of the company.
- Key Recent Developments – A brief on recent news about the company.

Reasons to Buy

Get detailed information on the company’s financial deals that enable you to understand the company’s expansion/divestiture and fund requirements
- The profile enables you to analyze the company’s financial deals by region, by year, by business segments and by type, for a five year period.

Understand the company’s business segments’ expansion / divestiture strategy
- The profile presents deals from the company’s core business segments’ perspective to help you understand its corporate strategy.

Access elaborate information on the company’s recent financial deals that enable you to understand the key deals which have shaped the company
- Detailed information on major recent deals includes a summary of each deal, deal type, deal rationale, deal financials and Target Company’s key financial metrics and ratios.

Equip yourself with detailed information about the company’s operations to identify potential customers and suppliers.
- The profile analyzes the company’s business structure, locations and subsidiaries, key executives and key competitors.

Stay up-to-date on the major developments affecting the company
- Recent developments concerning the company presented in the profile help you track important events.

Gain key insights into the company for academic or business research
- Key elements such as break up of deals into categories and information on detailed major deals are incorporated into the profile to assist your academic or business research needs.

Note*: Some sections may be missing if data is unavailable for the company.

【レポートの目次】

Table of Contents
Table of Contents 3
List of Tables 4
List of Figures 4
Seoul National University Hospital, Pharmaceuticals & Healthcare, Deals By Year, 2012 to YTD 2018 5
Seoul National University Hospital, Pharmaceuticals & Healthcare Deals By Type, 2012 to YTD 2018 6
Seoul National University Hospital, Pharmaceuticals & Healthcare, Deals By Region, 2012 to YTD 2018 7
Seoul National University Hospital, Pharmaceuticals & Healthcare, Deals By Therapy Area, 2012 to YTD 2018 8
Seoul National University Hospital, Medical Devices Deals, 2012 to YTD 2018 9
Seoul National University Hospital, Pharmaceuticals & Healthcare, Deals Summary, 2012 to YTD 2018 10
Seoul National University Hospital, Pharmaceuticals & Healthcare, Deal Details 11
Partnerships 11
Sequenom Enters into Agreement with Seoul National University Hospital 11
Agilent Technologies Enters Into Co-Development Agreement With Seoul National University Hospital 12
National Cancer Institute Enters Into Co-Development Agreement With Seoul National University Hospital For Proteomic Technologies 13
Seoul National University Hospital – Key Competitors 14
Seoul National University Hospital – Key Employees 15
Seoul National University Hospital – Locations And Subsidiaries 16
Head Office 16
Other Locations & Subsidiaries 16
Recent Developments 17
Government and Public Interest 17
Nov 04, 2017: Methotrexate drug holiday improves flu vaccine efficacy in rheumatoid arthritis patients 17
Product News 18
Sep 10, 2017: Domestic artificial self-expandable pulmonary valve with minimized immune rejection to complete a clinical trial and ready to make headway into the overseas market 18
Appendix 20
Methodology 20
About GlobalData 20
Contact Us 20
Disclaimer 20

List of Tables
Seoul National University Hospital, Pharmaceuticals & Healthcare, Key Facts 2
Seoul National University Hospital, Pharmaceuticals & Healthcare, Deals By Year, 2012 to YTD 2018 5
Seoul National University Hospital, Pharmaceuticals & Healthcare Deals By Type, 2012 to YTD 2018 6
Seoul National University Hospital, Pharmaceuticals & Healthcare, Deals By Region, 2012 to YTD 2018 7
Seoul National University Hospital, Deals By Therapy Area, 2012 to YTD 2018 8
Seoul National University Hospital, Medical Devices Deals, 2012 to YTD 2018 9
Seoul National University Hospital, Pharmaceuticals & Healthcare, Deals Summary, 2012 to YTD 2018 10
Sequenom Enters into Agreement with Seoul National University Hospital 11
Agilent Technologies Enters Into Co-Development Agreement With Seoul National University Hospital 12
National Cancer Institute Enters Into Co-Development Agreement With Seoul National University Hospital For Proteomic Technologies 13
Seoul National University Hospital, Key Competitors 14
Seoul National University Hospital, Key Employees 15
Seoul National University Hospital, Other Locations 16
Seoul National University Hospital, Subsidiaries 16

List of Figures
Seoul National University Hospital, Pharmaceuticals & Healthcare, Deals by Type, 2012 to YTD 2018 2
Seoul National University Hospital, Pharmaceuticals & Healthcare, Deals By Year, 2012 to YTD 2018 2
Seoul National University Hospital, Pharmaceuticals & Healthcare, Deals By Region, 2012 to YTD 2018 2
Seoul National University Hospital, Pharmaceuticals & Healthcare, Deals By Therapy Area, 2012 to YTD 2018 2
Seoul National University Hospital, Pharmaceuticals & Healthcare, Deals By Year, 2012 to YTD 2018 5
Seoul National University Hospital, Pharmaceuticals & Healthcare, Deals by Type, 2012 to YTD 2018 6
Seoul National University Hospital, Pharmaceuticals & Healthcare, Deals By Region, 2012 to YTD 2018 7
Seoul National University Hospital, Pharmaceuticals & Healthcare, Deals By Therapy Area, 2012 to YTD 2018 8
Seoul National University Hospital, Medical Devices Deals, 2012 to YTD 2018 9

★海外企業調査レポート[Seoul National University Hospital:製薬・医療:M&Aディール及び事業提携情報]についてメールでお問い合わせはこちら

■おすすめ企業レポート■
  • Innovent Biologics Inc:製薬・医療:M&Aディール及び事業提携情報
    Summary Innovent Biologics Inc (Innovent Biologics) is a biopharmaceutical company that discovers, develops and manufactures monoclonal antibodies. The company offers monoclonal antibodies such as IBI301, IBI302 and IBI303, among others. Its products are used for the treatment of non-Hodgkin’s lymph …
  • Hooper Holmes Inc (HH)-製薬・医療分野:企業M&A・提携分析
    Summary Hooper Holmes Inc (Hooper Holmes) is a provider of health and screening services. The company provides health services such as individual screenings at home or work, onsite screenings for small and large companies, remote screenings for individuals and eligible family members, convenient wal …
  • ADMA Biologics Inc (ADMA):製薬・医療:M&Aディール及び事業提携情報
    Summary ADMA Biologics Inc (ADMA Biologics) is an integrated biopharmaceutical and specialty immunoglobulin company that develops, produces, and commercializes specialty biologics to treat immune deficiencies and prevent certain infectious diseases. The company develops RI-002, is a specialty plasma …
  • Idemitsu Kosan Co Ltd (5019):石油・ガス:M&Aディール及び事業提携情報
    Summary Idemitsu Kosan Co Ltd (Idemitsu) is an integrated energy company that explores, produces, refines, and sells oil and gas, lubricants, and petroleum products. The company manufactures agricultural chemicals, agricultural materials, and other chemicals. It explores, develops and extracts coal, …
  • ASC Pty Ltd:企業の戦略・SWOT・財務情報
    ASC Pty Ltd - Strategy, SWOT and Corporate Finance Report Summary ASC Pty Ltd - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service offerings and corporate act …
  • GNI Group Ltd (2160):企業の財務・戦略的SWOT分析
    Summary GNI Group Ltd (GNI) is a healthcare service provider that researches, develops, manufactures and markets pharmaceutical drugs. The company’s business operations consist of drug discovery activities such as drug discovery research, drug discovery infrastructure, fundamental drug discovery and …
  • XTL Biopharmaceuticals Ltd (XTLB):企業の財務・戦略的SWOT分析
    Summary XTL Biopharmaceuticals Ltd (XTL) is a drug development company that focuses on the acquisition and development of late-stage pharmaceutical product candidates for the treatment of unmet clinical needs. The company’s pipeline products include hCDR1 peptide and recombinant human erythropoietin …
  • Clay Electric Cooperative, Inc.:企業の戦略的SWOT分析
    Clay Electric Cooperative, Inc. - Strategic SWOT Analysis Review provides a comprehensive insight into the company’s history, corporate strategy, business structure and operations. The report contains a detailed SWOT analysis, information on the company’s key employees, key competitors and major pro …
  • Boehringer Ingelheim GmbH:企業の戦略・SWOT・財務分析
    Boehringer Ingelheim GmbH - Strategy, SWOT and Corporate Finance Report Summary Boehringer Ingelheim GmbH - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service …
  • Innate Pharma SA (IPH):企業の財務・戦略的SWOT分析
    Summary Innate Pharma SA (Innate Pharma) is a biotechnology company developing antibodies to treat cancer by harnessing the immune system. It offers Lumoxiti, a CD22-directed immunotoxin for the treatment of relapsed or refractory hairy cell leukemia (HCL). The company is investigating drugs against …
  • Empresa Electrica Corani SA (COR1U):電力:M&Aディール及び事業提携情報
    Summary Empresa Electrica Corani SA (Empresa Electrica), a subsidiary of Empresa Nacional de Electricidad Bolivia, is a renewable energy company that develops and operates hydroelectric power plants and wind farms. The company offers operation and maintenance, project development, and technical serv …
  • Empire Energy Group Ltd (EEG):企業の財務・戦略的SWOT分析
    Summary Empire Energy Group Ltd (EEGL), formerly Imperial Corp Ltd is an oil and gas company that offers exploration and production programs. The company produces and develops oil and gas assets; and has interest in onshore oil and gas fields in Mid Con property and Appalachia property. It has onsho …
  • Verizon Communications Inc (VZ):電力:M&Aディール及び事業提携情報
    Summary Verizon Communications Inc. (Verizon) provides communications, information and entertainment products and services. The company offers a comprehensive range of voice, data and video services and solutions through its wireless and wireline networks. Its multimedia offerings include music, vid …
  • Ipsen SA (IPN):企業の財務・戦略的SWOT分析
    Ipsen SA (IPN) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key strengths and weaknesses and the po …
  • Cognizant Technology Solutions Corporation:戦略・SWOT・企業財務分析
    Cognizant Technology Solutions Corporation - Strategy, SWOT and Corporate Finance Report Summary Cognizant Technology Solutions Corporation - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, …
  • Stratos Product Development LLC-医療機器分野:企業M&A・提携分析
    Summary Stratos Product Development LLC (Stratos) is a provider of product development solutions. The company offers medical product development, and product design and strategy services. It offers services which include product strategy, research, industrial design and interaction design. The compa …
  • Enbridge Energy Partners, L.P.:企業の戦略・SWOT・財務情報
    Enbridge Energy Partners, L.P. - Strategy, SWOT and Corporate Finance Report Summary Enbridge Energy Partners, L.P. - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product a …
  • Banco Bilbao Vizcaya Argentaria SA:戦略・SWOT・企業財務分析
    Banco Bilbao Vizcaya Argentaria SA - Strategy, SWOT and Corporate Finance Report Summary Banco Bilbao Vizcaya Argentaria SA - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, p …
  • North Eastern Electric Power Corporation Ltd:企業の戦略的SWOT分析
    North Eastern Electric Power Corporation Ltd - Strategic SWOT Analysis Review provides a comprehensive insight into the company’s history, corporate strategy, business structure and operations. The report contains a detailed SWOT analysis, information on the company’s key employees, key competitors …
  • Purdue Pharma LP:製薬・医療:M&Aディール及び事業提携情報
    Summary Purdue Pharma LP (Purdue) is a privately held, US-based pharmaceutical company which develops pharmacologic therapies for the treatment and management of pain. The company undertakes the research, development, manufacture and marketing of prescription medicines and over-the-counter (OTC) med …

◆H&Iグローバルリサーチ株式会社のお客様(例)◆